spike
protein
major
structur
glycoprotein
coronaviru
cov
causal
agent
sever
acut
respiratori
syndrom
sar
protein
potent
target
sarsspecif
cellmedi
immun
respons
howev
mechan
cov
pathogenesi
sar
role
special
ctl
viru
clearanc
still
larg
uncharacter
describ
studi
lead
identif
novel
hlaa
epitop
conserv
region
protein
first
differ
sarscov
sequenc
analyz
predict
eight
candid
peptid
conserv
region
protein
base
upon
hlaa
bind
proteosom
cleavag
four
eight
candid
peptid
test
hlaa
bind
assay
among
four
candid
peptid
vlndilsrl
induc
specif
ctl
ex
vivo
pbl
healthi
donor
b
transgen
mice
immun
plasmid
encod
fulllength
protein
immun
mice
releas
lyse
target
cell
upon
stimul
peptidepuls
autolog
dendrit
cell
comparison
candid
result
suggest
natur
process
epitop
propos
epitop
help
character
mechan
viru
control
immunopatholog
sarscov
infect
sever
acut
respiratori
syndrom
sar
newli
emerg
infecti
diseas
caus
sarsassoci
coronaviru
sarscov
may
origin
wild
anim
first
occurr
sar
rapidli
spread
around
world
along
intern
airtravel
rout
reach
five
contin
result
sever
hundr
death
recent
epidem
sar
occur
beij
anhui
china
april
origin
laboratori
contamin
updat
see
inform
although
outbreak
seem
sar
remain
safeti
concern
possibl
reintroduct
sarslik
coronaviru
slcov
human
risk
escap
sarscov
laboratori
importantli
new
recombin
viru
deriv
human
swine
andor
avian
influenza
viru
might
reemerg
new
sarscov
type
much
like
recent
emerg
novel
swineorigin
influenza
human
thu
essenti
develop
variou
distinct
strategi
combat
highli
contagi
diseas
publish
literatur
report
high
titr
neutral
antibodi
sarscovspecif
cytotox
lymphocyt
ctl
respons
detect
patient
recov
sar
level
respons
correl
well
diseas
outcom
henc
humor
cellular
immun
respons
appear
crucial
clearanc
sarscov
infect
immun
respons
rais
directli
sever
sarscov
protein
target
spike
structur
glycoprotein
particular
induc
robust
immun
respons
suggest
play
import
role
system
clearanc
sarscov
viral
surfac
protein
involv
host
cell
receptor
recognit
viru
attach
entri
adapt
evolut
protein
thu
contribut
sarscov
overcom
speci
barrier
henc
mani
vaccin
therapeut
sarscov
target
protein
consid
cytotox
tcell
respons
particip
clearanc
viru
recov
sar
patient
contribut
immunopatholog
earli
stage
diseas
one
attract
proteinbas
strategi
propos
elicit
sarscov
ctl
respons
clear
infect
end
detail
understand
proteinmedi
ctl
respons
essenti
develop
effect
treatment
vaccin
sarscov
depend
upon
underli
mechan
variou
immun
effector
protect
immun
identif
protect
antigen
recogn
epitop
basic
antigen
element
viru
structur
protein
function
induc
host
cellmedi
immun
respons
identif
ctlspecif
epitop
sarscov
protein
could
provid
basi
develop
sar
immunitybas
treatment
aid
understand
mechan
underli
sarscov
pathogenesi
hlaa
express
major
ethnic
identif
hlaa
sarscov
ctl
epitop
import
contribut
toward
understand
role
ctl
sarscov
pathogenesi
protect
current
sever
ctlspecif
sarscov
protein
epitop
identifi
context
hlaa
includ
complex
includ
like
addit
protein
ctl
epitop
exist
protein
rel
larg
size
usag
differ
detect
method
may
result
identif
novel
proteinderiv
epitop
turn
data
provid
advanc
toward
understand
mechan
sarscov
infect
contribut
develop
futur
sarscov
infect
intervent
strategi
studi
identifi
novel
sarssspecif
hlaa
epitop
conserv
among
sarscov
strain
base
bind
affinitybas
predict
proteosom
cleavag
site
predict
construct
panel
potenti
hlaa
ctl
peptid
protein
candid
peptid
evalu
bind
affin
hlaa
molecul
use
cellpeptid
bind
test
evalu
abil
hlaa
bind
peptid
provok
ctl
respons
peripher
blood
lymphocyt
pbl
pbl
prepar
major
histocompat
complex
mhc
match
healthi
donor
k
b
transgen
tg
mice
incub
dendrit
cell
dc
prepuls
peptid
interest
identifi
novel
sarscov
proteinderiv
ctl
epitop
vlndilsrl
capabl
prime
proteinspecif
ctl
respons
effect
ctl
respons
evidenc
cell
death
peptidepuls
peptidepuls
b
cell
find
studi
provid
insight
immunolog
characterist
spike
protein
provid
altern
strategi
futur
develop
sarscov
protein
ctl
epitopebas
vaccin
select
candid
ctl
epitop
deriv
sarscov
protein
two
criteria
conserv
differ
strain
sarscov
encompass
mani
sarscov
strain
possibl
ii
high
represent
gener
popul
ie
hlaa
align
amino
acid
residu
protein
eighteen
sarscov
strain
figur
strain
protein
select
predict
protein
specif
hlaa
ctl
epitop
base
presenc
hlaa
bind
motif
cleavag
site
proteasom
immunoproteasom
eight
candid
peptid
predict
synthes
figur
tabl
term
peptid
verifi
absenc
share
sequenc
homolog
human
murin
protein
use
blast
search
engin
http
wwwncbinlmnihgovblast
avoid
autoreact
respons
evalu
bind
affin
peptid
hlaa
molecul
cellpeptid
bind
test
use
cell
lack
transport
associ
antigen
process
tap
key
factor
involv
endogen
antigen
process
present
caus
empti
hlai
molecul
cell
surfac
unstabl
degrad
rapidli
cell
surfac
present
howev
exogen
epitop
peptid
bind
hlai
molecul
cell
surfac
becom
stabl
accordingli
peptideinduc
upregul
hlai
tapdefici
cell
use
monitor
peptid
bind
class
molecul
indic
bind
affin
peptid
hlai
molecul
higheraffin
peptid
induc
hlaa
express
cell
surfac
loweraffin
peptid
shown
tabl
eight
candid
peptid
highaffin
epitop
fi
respect
posit
control
peptid
bound
hlaa
strongli
fi
wherea
bind
observ
neg
control
hbcag
peptid
fi
investig
capac
candid
peptid
mobil
human
ctl
repertoir
pbl
ten
donor
stimul
vitro
dc
load
align
put
amino
acid
sequenc
protein
eighteen
sarscov
strain
dot
among
individu
sequenc
denot
nucleotid
consensu
candid
epitop
peptid
shown
bold
text
hlaa
motif
score
algorithm
syfpeithi
eight
peptid
also
predict
select
use
threshold
motif
threshold
proteasom
immunoproteasom
cleavag
site
increas
hlaa
molecul
cell
surfac
fi
mean
fitc
fluoresc
given
peptid
mean
fitc
fluoresc
without
peptid
mean
fitc
fluoresc
without
peptid
fi
indic
highaffin
peptid
fi
lowaffin
peptid
hlaa
peptid
use
posit
control
hlaa
abil
b
restrict
peptid
hbcag
use
neg
control
eight
candid
peptid
posit
control
peptid
neg
control
peptid
hbcag
cell
load
peptid
use
target
cell
cytotox
assay
eight
peptid
test
induc
tcell
specif
produc
respons
dc
puls
relev
peptid
posit
control
peptid
comparison
group
figur
furthermor
cell
could
lyse
cell
load
relev
peptid
posit
control
peptid
effici
group
figur
cytolysi
observ
specif
ctl
could
lyse
cell
load
irrelev
peptid
figur
due
limit
induct
secret
cell
frequenc
low
ctl
cytolysi
abil
group
exclud
studi
ex
vivo
result
show
exist
function
antisarscov
ctl
precursor
peripher
cell
repertoir
healthi
donor
furthermor
sarscovsderiv
peptid
could
induc
increas
protein
specif
secret
cell
frequenc
also
enhanc
cytolyt
capac
ctl
address
whether
immunogen
candid
peptid
natur
process
present
k
b
transgen
mice
immun
plasmid
contain
fulllength
cdna
encod
sarscov
protein
splenocyt
collect
mice
seven
day
four
weekli
inject
restimul
ex
vivo
mous
bone
marrowderiv
dc
load
candid
peptid
posit
peptid
irrelev
peptid
hbcag
dc
alon
addit
day
investig
product
cytolyt
abil
effector
ctl
cell
carri
follow
restimul
j
k
b
cell
load
correspond
peptid
use
target
cytotox
assay
shown
figur
ctl
mice
abl
lyse
three
candid
peptidespuls
j
b
cell
lyse
j
b
cell
alon
j
b
cell
load
irrelev
peptid
hbcag
et
ratio
three
candid
peptid
test
exhibit
lytic
capac
et
ratio
compar
posit
control
peptid
figur
accord
result
cytolyt
assay
bulk
ctl
releas
respons
dc
puls
posit
control
peptid
puls
irrelev
peptid
hbcag
dc
alon
figur
among
three
test
candid
peptid
releas
follow
peptid
stimul
figur
known
sarscov
induc
strong
specif
ctl
respons
infect
patient
besid
high
titr
neutral
antibodi
furthermor
ctl
respons
level
correl
diseas
outcom
suggest
ctl
respons
crucial
clearanc
sarscov
among
encod
protein
sarscov
genom
protein
current
consid
import
target
prime
host
immun
respons
report
inflammatori
cell
influx
airway
macrophag
massiv
releas
cytokin
occur
peak
sar
infect
thu
studi
predict
valid
novel
ctl
epitop
sarscov
protein
use
two
predict
system
identifi
candid
ctl
epitop
protein
ie
peptid
predict
method
combin
proteosom
cleavag
site
predict
system
improv
predict
accuraci
eight
predict
peptid
verifi
via
mhc
peptid
bind
assay
tabl
among
eight
candid
peptid
exhibit
highest
capac
induc
potent
ctl
secret
lyse
target
cell
hlaa
healthi
donor
pbl
figur
vivo
investig
show
plasmid
encod
fulllength
sarscov
gene
elicit
strong
ctl
respons
b
transgen
mice
ctl
could
produc
substanti
amount
kill
target
cell
peptidespecif
hlaa
manner
figur
suggest
predict
candid
peptid
nativ
epitop
capabl
prime
ctl
respons
vivo
found
candid
peptid
held
greatest
abil
secret
kill
target
cell
vivo
figur
anoth
candid
peptid
fail
induc
potent
peptid
specif
ctl
tg
mice
figur
despit
highest
abil
comparison
rest
vitro
stimul
set
figur
studi
predict
valid
novel
ctl
epitop
sarscov
protein
vlndilsrl
may
due
uniqu
predict
method
use
studi
combin
strategi
predict
ie
peptid
predict
method
combin
proteosom
cleavag
site
predict
system
previou
studi
use
singl
method
hla
peptid
bind
predict
overlap
peptid
strategi
suggest
differ
predict
strategi
might
lead
differ
result
case
predict
candid
peptid
requir
addit
valid
method
ensur
accuraci
studi
also
determin
among
eight
peptid
predict
four
could
potent
prime
ctl
produc
signific
lyse
target
cell
although
peptid
exhibit
potenc
ctl
prime
howev
zhou
et
al
report
found
one
predict
peptid
could
stimul
secret
target
cell
lysi
may
reflect
differ
stimul
use
studi
zhou
use
peptid
stimul
effector
cell
directli
use
dc
load
candid
peptid
argu
use
dc
stimul
cell
ex
vivo
studi
dc
potent
apc
prime
cell
present
peptid
cell
sarscov
protein
specif
ctl
dna
vaccineimmun
b
tg
mice
studi
identifi
novel
conserv
hlaa
epitop
spike
protein
sarscov
propos
newli
identifi
epitop
could
use
evalu
sarscovspecif
tcell
respons
cours
sar
infect
treatment
epitop
also
aid
character
viru
control
mechan
immunopatholog
sarscov
infect
ultim
find
may
relev
develop
ethnic
unbias
wide
applic
immunotherapeut
approach
sar
diseas
identifi
potenti
hlaa
peptid
within
protein
sarscov
strain
combin
two
comput
algorithm
util
predict
algorithm
matrixbas
method
allow
predict
mhc
bind
site
antigen
sequenc
mhc
classi
allel
restrict
analysi
allel
sinc
preval
larg
percentag
major
ethnic
extens
studi
hla
classi
antigen
also
allow
predict
standard
proteasom
immunoproteasomal
cleavag
site
antigen
sequenc
simultan
predict
mhc
bind
proteasom
cleavag
site
antigen
sequenc
lead
identif
potenti
tcell
epitop
second
algorithm
syfpeithi
develop
h
g
rammense
et
al
rank
peptid
accord
score
take
account
presenc
primari
secondari
mhcbind
anchor
residu
mer
peptid
score
exceed
select
syfpeithi
amino
acid
sequenc
sarscov
analyz
comput
program
exist
acid
peptid
predict
bind
candid
peptid
synthes
shenyou
biotech
shanghai
china
purifi
revers
phase
hplc
confirm
mass
spectrometri
publish
hlaa
peptid
klpddfmgcv
deriv
protein
sarscov
use
posit
control
hlaa
abil
hbcagderiv
b
restrict
peptid
hbcag
ayrppnapil
use
neg
control
lyophil
peptid
dissolv
pb
concentr
mgml
store
aliquot
individu
select
flow
cytometri
screen
use
monoclon
antibodi
buffi
coat
normal
donor
purchas
southwest
hospit
third
militari
medic
univers
chongq
china
pbl
healthi
donor
separ
ficollhypaqu
densiti
gradient
tbd
inc
tianjin
china
wash
three
time
phosphatebuff
salin
pb
resuspend
medium
gibco
brl
supplement
lglutamin
mgml
penicillin
ul
streptomycin
mgl
fetal
calf
serum
fc
plate
plate
cell
per
well
human
tapdefici
cell
line
cell
line
produc
mab
purchas
american
type
cultur
collect
cell
line
maintain
medium
supplement
fetal
bovin
serum
penicillinstreptomycin
cell
line
maintain
dmem
contain
fc
glucos
penicillin
ul
streptomycin
mgl
b
cell
gener
gift
dr
w
martin
kast
norri
comprehens
cancer
center
lo
angel
ca
dr
jehad
charo
max
delbruck
center
medicin
berlin
germani
transfect
hla
chimer
molecul
contain
domain
human
hlaa
mous
b
serv
model
system
hla
restrict
respons
b
j
cell
line
maintain
medium
gibco
brl
plu
calf
serum
supplement
glucos
penicillin
ul
streptomycin
mg
l
cell
line
mention
kept
humidifi
atmospher
co
air
b
transgen
tg
mice
purchas
jackson
laboratori
bar
harbor
experiment
purpos
six
eight
weekold
mice
use
cell
surfac
hlaa
express
assess
flow
cytometri
use
fluorescein
isothiocyan
fitc
label
mab
sterotec
ltd
oxford
uk
mice
kept
spf
anim
care
facil
experi
perform
accord
guidelin
institut
anim
committe
tmmu
bind
assay
candid
peptid
candid
peptid
test
individu
capac
bind
molecul
surfac
human
tapdefici
cell
briefli
cell
incub
candid
peptid
human
sigma
st
loui
mo
serumfre
hour
co
atmospher
express
hlaa
cell
determin
stain
fitcconjug
mab
data
analyz
use
facscalibur
flow
cytomet
becton
dickinson
mountain
view
ca
cellquest
softwar
becton
dickinson
publish
peptid
hbcag
serv
posit
neg
control
respect
former
known
bind
molecul
high
affin
latter
identifi
mous
epitop
littl
bind
affin
molecul
fluoresc
index
fi
calcul
follow
fi
mean
fitc
fluoresc
given
peptid
mean
fitc
fluoresc
without
peptid
mean
fitc
fluoresc
without
peptid
peptid
fi
regard
highaffin
epitop
human
peripher
blood
monocytederiv
dc
gener
describ
previous
minor
modif
briefli
human
pbl
suspend
serumfre
allow
adher
plate
final
concentr
mlwell
cultur
hour
nonadher
cell
gentli
remov
warm
medium
result
adher
cell
cultur
medium
supplement
fc
ngml
recombin
human
r
system
minneapoli
mn
uml
recombin
human
granulocytemacrophag
coloni
stimul
factor
gmcsf
sandoz
basel
switzerland
co
everi
two
day
onehalf
medium
replac
fresh
medium
contain
doubl
concentr
gmcsf
indic
cell
suspens
collect
analysi
surfac
phenotyp
differ
stage
develop
five
day
cultur
dc
harvest
subsequ
experi
pure
confirm
analysi
rel
dcspecif
phenotyp
typic
dc
morpholog
ngml
recombin
human
tumor
necrosi
factor
peprotech
rocki
hill
nj
ad
medium
induc
phenotyp
function
matur
hour
later
dc
use
prime
autolog
pbl
follow
dc
puls
peptid
presenc
hour
irradi
gy
use
pbl
ml
cultur
medium
cocultur
peptidepuls
irradi
autolog
dc
plate
presenc
ngml
recombin
human
peprotech
hour
iuml
human
sigma
ad
cultur
medium
lymphocyt
restimul
week
manner
three
day
second
round
restimul
induc
cell
harvest
test
cytokin
determin
cytotox
assay
plasmid
encod
sarscov
protein
construct
use
immun
b
transgen
mice
dose
pb
plasmid
inject
tibiali
anterior
muscl
mice
reinocul
four
time
everi
seven
day
condit
studi
bone
marrowderiv
dc
gener
transgen
mice
previous
describ
modif
dc
puls
peptid
presenc
hour
irradi
gy
use
spleen
asept
remov
final
schedul
immun
splenic
singlecel
suspens
harvest
cultur
plate
densiti
mlwell
presenc
peptideload
irradi
syngen
dc
day
six
cultur
induc
cell
harvest
test
cytokin
determin
cytotox
assay
cytotox
activ
ctl
determin
standard
cr
releas
assay
previous
describ
modif
human
cytotox
assay
dc
deriv
healthi
donor
incub
candid
peptid
use
stimul
autolog
healthi
donor
pbl
cell
load
relev
peptid
use
target
cell
cytotox
assay
posit
control
group
pbl
stimul
puls
autolog
dc
pbl
stimul
hbcag
puls
autolog
dc
serv
neg
control
group
dnaimmun
mice
cytotox
assay
target
cell
j
cell
load
candid
peptid
posit
control
peptid
irrelev
peptid
hbcag
j
cell
alon
first
cell
andor
j
cell
load
peptid
human
incub
hour
peptidepuls
cell
andor
j
cell
label
cr
sodium
chromat
na
cro
perkinelm
life
scienc
boston
minut
crlabel
target
cell
wash
three
time
mix
grade
dose
effector
plate
incub
hour
total
supernat
collect
well
radioact
count
gamma
counter
assay
perform
triplic
percent
specif
lysi
determin
accord
follow
formula
percent
specif
lysi
mean
experiment
cpm
mean
spontan
cpm
mean
maximum
cpm
mean
spontan
cpm
spontan
maximum
releas
determin
incub
label
target
medium
alon
hcl
respect
spontan
releas
alway
maximum
releas
elispot
assay
perform
use
commerci
avail
kit
ucytech
netherland
accord
manufactur
instruct
publish
literatur
modif
autolog
dc
puls
candid
peptid
use
stimul
pbl
immun
mice
effector
cell
stimul
cell
seed
polyvinyliden
fluorid
pvdf
back
micropl
precoat
mab
incub
hour
cell
remov
plate
process
describ
instruct
result
spot
count
stereomicroscop
carl
zeiss
thornwood
ny
magnif
brown
andor
blue
color
spot
fuzzi
border
score
spotform
cell
sfc
posit
control
load
dc
use
stimul
cell
hbcag
load
dc
dc
alon
medium
use
neg
control
neg
control
valu
alway
sfc
per
input
cell
result
consid
posit
least
pbl
detect
assay
run
triplic
result
repres
three
experi
